BioCentury
ARTICLE | Clinical News

NGX-4010 regulatory update

September 29, 2008 7:00 AM UTC

NeurogesX Inc. (NASDAQ:NGSX), San Carlos, Calif. Product: NGX-4010 Business: Neurology NeurogesX submitted a response to EMEA's Day 120 questions on an MAA for NGX-4010 to treat peripheral neuropathi...